The Middle-East & Africa Fluoroscopy Market is expected to register a CAGR of 3.3% during the forecast period. The major factors driving the growth of the market in the Middle-East & Africa are due to rising demand for minimally-invasive surgeries, growing geriatric population and prevalence of chronic diseases, and increasing use of fluoroscopy in pain management.

Furthermore, in Sub-Saharan Africa, by 2030, chronic diseases like cancer, heart disease, and kidney failure will become the major killers and chronic diseases will account for 42% of all deaths in the region, up from 25% in 2014, as per World Health Organization (WHO).

Thus, owing to the above factors the market is expected to show significant growth over the forecast period. However, the side effects associated with radiation are expected to hinder the market growth over the forecast period.

Key Market Trends

Cardiovascular Segment is Expected to Hold Major Market Share under Application over the Forecast Period

The rising prevalence of cardiovascular diseases across the Middle-East & Africa is a major factor driving the growth of the market. South Africa has one of the highest levels of overweight and obesity in the world which is a contributing factor for the disease.

The burden of cardiovascular disease is increasing rapidly in Africa, and it is now a public health problem throughout the African Region. Some of the major cardiovascular diseases are hypertension, stroke, cardiomyopathies, and coronary heart disease as per WHO.

According to an article published in 2016, in South Africa, there are around 210 people die from heart disease every day. This is due to a lack of awareness around cardiovascular disease. In fact, after HIV/Aids, heart disease and stroke are the second biggest killers in South Africa. Non-communicable diseases (lifestyle-related conditions), including heart disease, are estimated to account for 43% of the deaths of adults in the country. In addition, as per Statistics South Africa, in 2018 approximately 4.38 million South Africans suffered from hypertension, making it the most prevalent chronic health condition in the country.

According to the Heart and Stroke Foundation South Africa, every hour in South Africa five people have heart attacks, 10 people have strokes and of those events, 10 people will actually die from it.

Thus, the high prevalence of cardiovascular diseases is expected to drive the market in the near future.

Competitive Landscape

The Middle-East & African Fluoroscopy Devises Market is consolidated competitive. The major market players are focusing on technological advancements and reducing the side effects of the procedures. Some of the players who are currently dominating the market are GE Healthcare (GE Company), Canon Medical Systems Corporation, Siemens Healthineers, Koninklijke Philips NV, Hitachi Medical Systems, Shimadzu Medical, Hologic Inc and Varex Imaging Corporation.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support